SA
ABMD logo
Abiomed, Inc.(ABMD)
Closing price · checked 4:30 PM ETAbout this dataData status
$381.02▲0.00 (0.00%)

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Abiomed, Inc. (ABMD)

EV to Sales

15.23×

TTM · Retrieved:

ABMD logo

ABMD EV to Sales

Current (TTM)15.23×
ABMD EV/Sales (7.57× → 15.23×)
Powered by
High-resolution chart · PNG

What is ev to sales?

Enterprise value to sales ratio.

ABMD ev to sales history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Abiomed, Inc. EV to Sales — Annual fiscal periods
Period endingEV to SalesChange
14.4612×−13.41%
16.7014×+120.61%
7.5704×−52.85%
16.0553×−25.55%
21.5665×+78.15%
12.1057×+0.92%
11.9958×−4.27%
12.531×+129.36%
5.4635×+22.31%
4.4669×−33.24%
6.6906×+26.69%
5.2813×+21.12%
4.3602×+88.73%
2.3103×−67.93%
7.2029×+21.26%
5.9403×−19.70%
7.3973×+26.48%
5.8484×−9.51%
6.463×+303.84%
1.6004×−77.28%
7.0431×−25.05%
9.3976×−16.06%
11.1958×+458.25%
2.0055×−27.07%
2.7498×+9.86%
2.5029×−28.54%
3.5025×−30.87%
5.0665×−26.80%
6.9216×−59.85%
17.239×−44.43%
31.0197×+39.08%
22.3037×+126.82%
9.8332×−28.74%
13.7995×+82.85%
7.5471×−0.25%
7.5662×—

Frequently asked questions: ABMD ev to sales

What is Abiomed, Inc. (ABMD)'s current ev to sales?

Abiomed, Inc. (ABMD)'s latest reported ev to sales (TTM) is 15.23× as of Nov 22, 2026. Enterprise value to sales ratio.

How much historical ev to sales data is available for ABMD?

Stock Alarm Pro provides 36 dated annual fiscal periods observations for Abiomed, Inc. (ABMD)'s ev to sales, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ABMD's ev to sales to peers or set an alert?

You can open ABMD's ev to sales in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ABMD delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.